CN110521874A - A kind of method of EPA and DHA deposition in promotion chicken - Google Patents
A kind of method of EPA and DHA deposition in promotion chicken Download PDFInfo
- Publication number
- CN110521874A CN110521874A CN201910796957.4A CN201910796957A CN110521874A CN 110521874 A CN110521874 A CN 110521874A CN 201910796957 A CN201910796957 A CN 201910796957A CN 110521874 A CN110521874 A CN 110521874A
- Authority
- CN
- China
- Prior art keywords
- epa
- diet
- chicken
- dha
- isoflavones
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241000287828 Gallus gallus Species 0.000 title claims abstract description 47
- 230000008021 deposition Effects 0.000 title claims abstract description 15
- 238000000034 method Methods 0.000 title claims abstract description 10
- 235000005911 diet Nutrition 0.000 claims abstract description 45
- 230000037213 diet Effects 0.000 claims abstract description 45
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 claims abstract description 34
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 claims abstract description 23
- 235000008696 isoflavones Nutrition 0.000 claims abstract description 23
- 150000002515 isoflavone derivatives Chemical class 0.000 claims abstract description 21
- 235000020661 alpha-linolenic acid Nutrition 0.000 claims abstract description 17
- 229960004488 linolenic acid Drugs 0.000 claims abstract description 16
- 235000021388 linseed oil Nutrition 0.000 claims description 31
- 239000000944 linseed oil Substances 0.000 claims description 31
- 230000001737 promoting effect Effects 0.000 claims description 6
- 239000000654 additive Substances 0.000 claims description 4
- 230000000996 additive effect Effects 0.000 claims description 4
- 235000013372 meat Nutrition 0.000 claims description 4
- 238000002360 preparation method Methods 0.000 claims description 2
- 230000015572 biosynthetic process Effects 0.000 abstract description 4
- 238000003786 synthesis reaction Methods 0.000 abstract description 4
- MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 description 64
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 description 33
- 235000020673 eicosapentaenoic acid Nutrition 0.000 description 33
- 229960005135 eicosapentaenoic acid Drugs 0.000 description 33
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 description 33
- 235000020669 docosahexaenoic acid Nutrition 0.000 description 32
- 229940090949 docosahexaenoic acid Drugs 0.000 description 32
- 235000013330 chicken meat Nutrition 0.000 description 31
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 13
- 210000002381 plasma Anatomy 0.000 description 12
- 238000012545 processing Methods 0.000 description 11
- 150000003626 triacylglycerols Chemical class 0.000 description 9
- 108010024636 Glutathione Proteins 0.000 description 7
- 150000004671 saturated fatty acids Chemical class 0.000 description 7
- TUNFSRHWOTWDNC-UHFFFAOYSA-N Myristic acid Natural products CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 description 6
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 6
- 108010023302 HDL Cholesterol Proteins 0.000 description 5
- 108010028554 LDL Cholesterol Proteins 0.000 description 5
- WSMYVTOQOOLQHP-UHFFFAOYSA-N Malondialdehyde Chemical compound O=CCC=O WSMYVTOQOOLQHP-UHFFFAOYSA-N 0.000 description 5
- 239000003963 antioxidant agent Substances 0.000 description 5
- 230000003078 antioxidant effect Effects 0.000 description 5
- 235000006708 antioxidants Nutrition 0.000 description 5
- 235000014113 dietary fatty acids Nutrition 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 229930195729 fatty acid Natural products 0.000 description 5
- 239000000194 fatty acid Substances 0.000 description 5
- 150000004665 fatty acids Chemical class 0.000 description 5
- 229960003180 glutathione Drugs 0.000 description 5
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 5
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 238000004458 analytical method Methods 0.000 description 4
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 4
- 238000001543 one-way ANOVA Methods 0.000 description 4
- 210000002976 pectoralis muscle Anatomy 0.000 description 4
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 3
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 3
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 3
- 239000005642 Oleic acid Substances 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 235000012000 cholesterol Nutrition 0.000 description 3
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 3
- SECPZKHBENQXJG-FPLPWBNLSA-N palmitoleic acid Chemical compound CCCCCC\C=C/CCCCCCCC(O)=O SECPZKHBENQXJG-FPLPWBNLSA-N 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 238000006467 substitution reaction Methods 0.000 description 3
- 230000001228 trophic effect Effects 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- TWJNQYPJQDRXPH-UHFFFAOYSA-N 2-cyanobenzohydrazide Chemical compound NNC(=O)C1=CC=CC=C1C#N TWJNQYPJQDRXPH-UHFFFAOYSA-N 0.000 description 2
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 2
- 235000004431 Linum usitatissimum Nutrition 0.000 description 2
- 235000021360 Myristic acid Nutrition 0.000 description 2
- 235000021355 Stearic acid Nutrition 0.000 description 2
- 235000021342 arachidonic acid Nutrition 0.000 description 2
- 229940114079 arachidonic acid Drugs 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 238000004817 gas chromatography Methods 0.000 description 2
- 235000020778 linoleic acid Nutrition 0.000 description 2
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 235000020660 omega-3 fatty acid Nutrition 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 238000010010 raising Methods 0.000 description 2
- 239000011781 sodium selenite Substances 0.000 description 2
- 239000008117 stearic acid Substances 0.000 description 2
- XSXIVVZCUAHUJO-AVQMFFATSA-N (11e,14e)-icosa-11,14-dienoic acid Chemical compound CCCCC\C=C\C\C=C\CCCCCCCCCC(O)=O XSXIVVZCUAHUJO-AVQMFFATSA-N 0.000 description 1
- BBWMTEYXFFWPIF-CJBMEHDJSA-N (2e,4e,6e)-icosa-2,4,6-trienoic acid Chemical compound CCCCCCCCCCCCC\C=C\C=C\C=C\C(O)=O BBWMTEYXFFWPIF-CJBMEHDJSA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- JWZYQAITGQPZNM-UHFFFAOYSA-N 1-chloro-3-hydroxypropan-2-one Chemical compound OCC(=O)CCl JWZYQAITGQPZNM-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- UNMYWSMUMWPJLR-UHFFFAOYSA-L Calcium iodide Chemical compound [Ca+2].[I-].[I-] UNMYWSMUMWPJLR-UHFFFAOYSA-L 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 206010008111 Cerebral haemorrhage Diseases 0.000 description 1
- 206010008132 Cerebral thrombosis Diseases 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- 235000021297 Eicosadienoic acid Nutrition 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 201000001429 Intracranial Thrombosis Diseases 0.000 description 1
- 241000208202 Linaceae Species 0.000 description 1
- 240000006240 Linum usitatissimum Species 0.000 description 1
- MJVAVZPDRWSRRC-UHFFFAOYSA-N Menadione Chemical compound C1=CC=C2C(=O)C(C)=CC(=O)C2=C1 MJVAVZPDRWSRRC-UHFFFAOYSA-N 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 229910003424 Na2SeO3 Inorganic materials 0.000 description 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
- 235000021319 Palmitoleic acid Nutrition 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 102000019197 Superoxide Dismutase Human genes 0.000 description 1
- 108010012715 Superoxide dismutase Proteins 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 238000012742 biochemical analysis Methods 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 238000010241 blood sampling Methods 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 229910052927 chalcanthite Inorganic materials 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- SECPZKHBENQXJG-UHFFFAOYSA-N cis-palmitoleic acid Natural products CCCCCCC=CCCCCCCCC(O)=O SECPZKHBENQXJG-UHFFFAOYSA-N 0.000 description 1
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 1
- 229910000366 copper(II) sulfate Inorganic materials 0.000 description 1
- 239000006027 corn-soybean meal Substances 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- BVTBRVFYZUCAKH-UHFFFAOYSA-L disodium selenite Chemical compound [Na+].[Na+].[O-][Se]([O-])=O BVTBRVFYZUCAKH-UHFFFAOYSA-L 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 235000021323 fish oil Nutrition 0.000 description 1
- 235000004426 flaxseed Nutrition 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 235000001497 healthy food Nutrition 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 1
- XBDUTCVQJHJTQZ-UHFFFAOYSA-L iron(2+) sulfate monohydrate Chemical compound O.[Fe+2].[O-]S([O-])(=O)=O XBDUTCVQJHJTQZ-UHFFFAOYSA-L 0.000 description 1
- 229910000359 iron(II) sulfate Inorganic materials 0.000 description 1
- GOMNOOKGLZYEJT-UHFFFAOYSA-N isoflavone Chemical compound C=1OC2=CC=CC=C2C(=O)C=1C1=CC=CC=C1 GOMNOOKGLZYEJT-UHFFFAOYSA-N 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000011572 manganese Substances 0.000 description 1
- 229910000357 manganese(II) sulfate Inorganic materials 0.000 description 1
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 description 1
- ISPYRSDWRDQNSW-UHFFFAOYSA-L manganese(II) sulfate monohydrate Chemical compound O.[Mn+2].[O-]S([O-])(=O)=O ISPYRSDWRDQNSW-UHFFFAOYSA-L 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 150000004702 methyl esters Chemical class 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 235000021281 monounsaturated fatty acids Nutrition 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 235000020665 omega-6 fatty acid Nutrition 0.000 description 1
- 238000011022 operating instruction Methods 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 239000011236 particulate material Substances 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 210000001525 retina Anatomy 0.000 description 1
- 235000015921 sodium selenite Nutrition 0.000 description 1
- 229960001471 sodium selenite Drugs 0.000 description 1
- 238000002798 spectrophotometry method Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- QERYCTSHXKAMIS-UHFFFAOYSA-N thiophene-2-carboxylic acid Chemical compound OC(=O)C1=CC=CS1 QERYCTSHXKAMIS-UHFFFAOYSA-N 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 239000011647 vitamin D3 Substances 0.000 description 1
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011652 vitamin K3 Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910000368 zinc sulfate Inorganic materials 0.000 description 1
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 1
- 239000011686 zinc sulphate Substances 0.000 description 1
- RNZCSKGULNFAMC-UHFFFAOYSA-L zinc;hydrogen sulfate;hydroxide Chemical compound O.[Zn+2].[O-]S([O-])(=O)=O RNZCSKGULNFAMC-UHFFFAOYSA-L 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
- A01K67/02—Breeding vertebrates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/30—Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/30—Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms
- A23K10/37—Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms from waste material
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/116—Heterocyclic compounds
- A23K20/121—Heterocyclic compounds containing oxygen or sulfur as hetero atom
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/158—Fatty acids; Fats; Products containing oils or fats
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/70—Feeding-stuffs specially adapted for particular animals for birds
- A23K50/75—Feeding-stuffs specially adapted for particular animals for birds for poultry
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P60/00—Technologies relating to agriculture, livestock or agroalimentary industries
- Y02P60/80—Food processing, e.g. use of renewable energies or variable speed drives in handling, conveying or stacking
- Y02P60/87—Re-use of by-products of food processing for fodder production
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Polymers & Plastics (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Animal Husbandry (AREA)
- Zoology (AREA)
- Food Science & Technology (AREA)
- Physiology (AREA)
- Mycology (AREA)
- Molecular Biology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Health & Medical Sciences (AREA)
- Environmental Sciences (AREA)
- Birds (AREA)
- Animal Behavior & Ethology (AREA)
- Biodiversity & Conservation Biology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
The invention discloses a kind of methods of EPA and DHA deposition in promotion chicken, using the diet feeding dorking containing alpha-linolenic acid, and isoflavones are added in diet.It can promote the synthesis of EPA and DHA by the addition of isoflavones, so that EPA and DHA are effectively deposited in chicken, and then improve value of chicken, so that people can absorb EPA and DHA by edible chicken.
Description
Technical field
The present invention relates to broiler fodder technical field, EPA and DHA deposition in more particularly to a kind of promotion chicken
Method.
Background technique
EPA (Eicosapentaenoic Acid) i.e. eicosapentaenoic acid belongs to the serial polyunsaturated fatty acid of ω -3,
It is the indispensable important nutrient of human body, the content of cholesterol and triglycerides can be reduced, promotes internal saturated fatty acid generation
It thanks, the cardiovascular diseases such as prevention cerebral thrombosis, cerebral hemorrhage, hypertension.
DHA (Docosahexaenoic Acid) i.e. docosahexaenoic acid is nervous system cell growth and is maintained
A kind of main component is the important composition ingredient of brain and retina.
In order to supplement EPA, DHA, people generally select EPA, DHA health care product taken by purification, however, as EPA
With the deep sea fish oil and marine algae of DHA main source, due to fish overfishing, marine environmental pollution, yield and quality
Degradation is no longer satisfied ever-increasing market demand, therefore, still needs to develop the more natural intake side EPA, DHA
Formula.
Summary of the invention
In view of this, improving chicken nutriture value the invention discloses a kind of method of EPA and DHA deposition in promotion chicken
Value, and then by edible chicken, that is, ingestible EPA, DHA, and EPA the and DHA bioavailability of food source is higher.
To achieve the goals above, the present invention adopts the following technical scheme:
Application of the isoflavones in promoting chicken in EPA and DHA deposition.
Isoflavones promotes the application in chicken in the diet or diet additive of EPA and DHA deposition in preparation.
A kind of method of EPA and DHA deposition in promotion chicken, using the diet feeding dorking containing alpha-linolenic acid, and
Isoflavones is added in diet.
Isoflavones have different physiological roles, while alpha-linolenic acid (ALA) as n-3 precursor have synthesis EPA and
DHA ability (mainly realizes) that the addition of isoflavones may be by changing one by unsaturated enzyme and extension enzyme
Serial enzyme activity effect, promotes the efficiency of ALA Synthesis EPA and DHA and is deposited on it effectively in chicken.
Preferably, using the diet feeding dorking containing linseed oil, and isoflavones is added in diet;Linseed
Alpha-linolenic acid is rich in oil.
The diet of EPA and DHA deposition in a kind of promotion chicken, linseed oil content is 2%-4% in diet;Linseed oil
Middle alpha-linolenic acid content is 50-60%;Isoflavones additive amount is 20-60mg/kg in diet.
It can be seen via above technical scheme that compared with prior art, the invention discloses EPA in a kind of promotion chicken and
The method of DHA deposition, promotes the synthesis of EPA and DHA by the addition of isoflavones, so that EPA and DHA are effectively deposited on chicken
In meat, value of chicken is improved, so that people can absorb EPA and DHA by edible chicken.
Specific embodiment
The technical scheme in the embodiments of the invention will be clearly and completely described below, it is clear that described implementation
Example is only a part of the embodiment of the present invention, instead of all the embodiments.Based on the embodiments of the present invention, this field is common
Technical staff's every other embodiment obtained without making creative work belongs to the model that the present invention protects
It encloses.
Embodiment 1
It selects the fast large-scale Lingnan yellow broiler (public affairs) of 900 29 ages in days (597 ± 0.00g of weight BW) to be used as test chicken, presses
Diet ingredient difference is divided into 5 processing groups (table 1), 6 repetitions of every processing, 30 chickens of each repetition.Test chicken ground is flat to support, often
(30) raisings are repeated in a column, particulate material and drinking-water is freely eaten.It is carried out according to conventinal breeding operating instruction and immune programme
It raises and immune;Experimental period 29-66 age in days.
Table 1
Test uses corn-soybean meal Basic drawing, trophic level Primary Reference " fowl raising standard " (NY/T 33-
2004) be arranged, diet composition and trophic level calculated according to Chinese feed ingredient and nutritive value table (2018), diet composition and
As shown in table 2, diet fatty acid composition is as shown in table 3 for trophic level (air bells dry basis).Each group diet is made using granulator
Pellet.
Table 2
Wherein,1Premix is that every kilogram of diet adds respectively:
Vitamin B1: 2.4mg (29-49 age in days), 2.1mg (50-66 age in days);
Vitamin B2: 4mg (29-49 age in days), 3mg (50-66 age in days);
Niacin: 17mg (29-49 age in days), 15mg (50-66 age in days);
Choline: 600mg (29-49 age in days), 500mg (50-66 age in days);
Vitamin A: 6000IU;Vitamin D3: 500IU;Vitamin E: 20IU;Vitamin K3: 0.50mg;Pantothenic acid: 10mg;
Vitamin B6: 3.5mg;Biotin: 0.15mg;Folic acid: 0.55:mg;Vitamin B12: 0.01mg;
Fe:80mg;Cu:7mg;Mn:60mg;Zn:75mg;I:0.35mg;Se:0.23mg is (respectively with ferrous sulfate monohydrate
FeSO4·H2O, cupric sulfate pentahydrate CuSO4·5H2O, manganese sulfate monohydrate MnSO4·H2O, monohydrate zinc sulphate ZnSO4·H2O, acid iodide
Calcium Ca (IO3)2·H2O and sodium selenite Na2SeO3Form addition).
2Trophic level is calculated value, with reference to Database of Feed (2018).
In table, LA group diet contains 4% lard;LA+LO group diet+2% linseed oil containing 2% lard;LO group diet contains 4%
Linseed oil;SI indicates 30mg/kg isoflavones.
In addition to adding SI, remaining ingredient forms phase with LA+LO group and LO group diet respectively for LA+LO+SI group and LO+SI group
Together, SI is added in premix.
Synthesizing isoflavones, (Synthetic isoflavone, SI, main component is 6- methyl -2- ethyl -7- propionyl
Oxygroup isoflavones, 98%) purity is greater than to be provided by Xinnandu Feed Science & Technology Co., Ltd., Guangdong.
The specific Component Percent (measured value) of linseed oil (Linseed oil, LO): alpha-linolenic acid (C18:3n-3)
58.3%, oleic acid (C18:1n-9) 17.1%, linoleic acid (C18:2n-6) 14.0%, stearic acid (C18:0) 4.0%, palmitinic acid
(C16:0) 5.1%, etc..
The specific Component Percent (measured value) of lard (Lard, LA): oleic acid (C18:1n-9) 40.2%, palmitinic acid (C16:
0) 23%, linoleic acid (C18:2n-6) 15.2%, stearic acid (C18:0) 14.1%, palmitoleic acid (C16:1n-7) 2.7%, meat
Myristic acid (C14:0) 1.3%, alpha-linolenic acid (C18:3n-3) 1.5%, etc..
Table 3
Note: the lower fatty acid of content is unlisted.
It when 66 age in days, is weighed again after fracture 12 hours to calculate average daily gain (ADG), is with each every repetition of processing
Unit record average daily gain (ADFI) calculates feed-weight ratio (F/G).2 are then chosen from the every repetition of each processing close to flat
The test chicken of equal weight carries out quiet vein blood sampling using anticoagulant heparin pipe;1200g is centrifuged 10 minutes separated plasma samples at 4 DEG C
Product, and -80 DEG C are stored in after blood plasma is in charge of until analysis.Broiler chicken acquires left pectoral sample after butchering, and moves on to -20 DEG C of refrigerators
It saves, is used for chest muscle content of fatty acid and composition measuring.
Plasma Biochemical analysis: it is determined always using commercial reagent box (Nanjing Jian Cheng Bioengineering Research Institute) spectrophotometry
Superoxide dismutase (T-SOD) activity, total antioxidant capacity (T-AOC), reduced glutathione (GSH), oxidized form paddy Guang
Sweet peptide (GSSG) and malonaldehyde (MDA) content.Then calculate GSH/GSSG ratio.Using automatic biochemistry analyzer (Holland
Selectra-proxl clinical chemistry systems) and matched reagent box (Zhongsheng Beikong Biological Science & Technology Co., Ltd.) measurement blood plasma
In total triglycerides (TG), total cholesterol (TCH), high-density lipoprotein cholesterol (HDL-C) and low density lipoprotein cholesterol
(LDL-C) concentration.
Content of fatty acid is measured with composition using gas chromatography (GC): accurately weighing 2.0g chest muscle meat sample freeze-dried powder
In hydrolysis pipe, 4mL chloracetyl-methanol solution (1:10) and the interior target hendecoic acid methyl esters of 1mL C11:0 (1mg/ml) is added
Solution covers tightly bottle cap and is placed in 2 hours of 80 DEG C of water-baths.7% potassium carbonate 5mL is added after taking out cooling, shaking is uniform, with
0.2um filter membrane, which is crossed, after the speed centrifugation 5min of 1200r/min is packed into sample introduction bottle, upper machine testing.
It is carried out using one-way ANOVA in SAS (version 9.1, SAS Institute, Cary, NC) statistical software
The data analysis of five processing groups, data are missed (SEM) with average value ± average and are indicated, linseed oil substitution level and soybean
The reciprocation of isoflavones is analyzed using GLM, using P < 0.05 as significance of difference judgment criteria.
1. growth performance
As shown in table 4, compared with LA diet, half is substituted with linseed oil or whole lards significantly reduce yellow-feather broiler
Average daily gain (ADFI), completely substitution reduce F/G;The whole BW and ADG of 29-66 age in days chicken be not by significant shadow
It rings.LO group diet improves 4.56% (P < 0.05) compared to the feed efficiency of LA group diet.
Table 4
Wherein,The standard error of SEM:5 processing group, n=6 (every group of 6 repetitions, 2 chickens of each repetition).
a,bColleague indicates that difference is not significant (P > 0.05) without letter, different significant P < 0.05 of lowercase letter indication difference).
1BW, weight;ADG, average daily gain;ADFI, average daily gain;F/G, feed-weight ratio.
2Refer to the P value of 5 processing group one-way ANOVA analysis.
3LO indicates that linseed oil dosage, linseed oil substitute half or whole lards.
2. blood plasma is anti-oxidant and lipid-metabolism index
As shown in table 5, half is substituted with linseed oil or whole lards do not make significant difference to broiler chicken blood plasma Antioxidant Indexes
(P>0.05).When SI is added to linseed oil diet, LO+SI diet group broiler chicken blood plasma T-SOD activity is significantly higher than LO and LA+
LO group.Five kinds of diets do not make significant difference to blood plasma T-AOC, MDA, GSH and GSSG content, but the diet group (LA+LO+SI containing SI
And LO+SI) GSH/GSSG ratio be above LA+LO and LO group (P < 0.05).Compared with LA group, in linseed oil diet TG and
TCH content is substantially reduced, and especially in the presence of SI, TG and TCH level can be further decreased.Linseed oil substitutes pig
There are significant interactions for the influence of oil level and SI to plasma TC H content, but each diet contains chicken plasma HDL-C or LDL-C
Amount does not make significant difference.
Table 5
Wherein,The standard error of SEM:5 processing group, n=6 (every group of 6 repetitions, 2 chickens of each repetition).
a,b,cColleague indicates that difference is not significant (P > 0.05) without letter, different significant P < 0.05 of lowercase letter indication difference).
1T-AOC, total antioxidant capacity;T-SOD, total number born;GSH, reduced glutathione;GSSG, oxygen
Change type glutathione;MDA, malonaldehyde;TG, total triglycerides;TCH, total cholesterol;HDL-C, high-density lipoprotein cholesterol;
LDL-C, low density lipoprotein cholesterol.
2Refer to the P value of 5 processing group one-way ANOVA analysis.
3LO indicates that linseed oil dosage, linseed oil substitute half or whole lards.
3. chest muscle fatty acid forms
As shown in table 6, compared with LA group, ALA (C18:3n-3), the EPA (C20:5n-3) of the chicken containing linseed oil are eaten
Content is higher (P < 0.05), myristic acid (C14:0), palmitinic acid (C16:0), oleic acid (C18:1n-9), arachidonic acid (C20:
4n-6) and sour (C24:0) content of tetracosa carbon is lower.The saturated fatty acid (SFA) and n- for the chicken that diet is fed containing linseed oil
6/n-3 ratio is below the chicken (p < 0.05) fed with lard merely.Compared with LA group, the n-3 fatty acid of linseed oil group contains
Amount, PUFA content and PUFA/SFA ratio are higher (P < 0.05), but have no significant effect to the content of n-6 fatty acid.Work as addition
When 30mg/kg SI is into the diet containing linseed oil (LA+LO and LO), EPA content further increases (P < 0.05), DHA content
It dramatically increases.Show that the alpha-linolenic acid in diet can be effectively deposited in yellow-feather broiler muscle, and EPA can be effectively converted into
It is deposited in chicken;Addition isoflavones can further promote alpha-linolenic acid to be converted to EPA, turn again into linseed oil diet
Chemical conversion DHA is deposited in chicken.
Table 6
The standard error of SEM:5 processing group, n=6 (every group of 6 repetitions, 2 chickens of each repetition).
a,b,cColleague indicates that difference is not significant (P > 0.05) without letter, significant (the P < of different lowercase letter indication differences
0.05)。
1EPA: eicosapentaenoic acid, DHA: docosahexaenoic acid, SFA: saturated fatty acid, MUFA: monounsaturated fatty acid
Acid, PUFA: polyunsaturated fatty acid, n-3: including alpha-linolenic acid, EPA, DHA, n-6: including linoleic acid, eicosadienoic acid,
Eicosatrienoic acid, arachidonic acid.
2Refer to the P value of 5 processing group one-way ANOVA analysis.
3LO indicates that linseed oil dosage, linseed oil substitute half or whole lards.
In conclusion feed efficiency can be improved with linseed oil substitution half lard or whole lards, make Lingnan Yellow chicken
Meat be rich in n-3 polyunsaturated fatty acid (ALA, EPA and DHA), and reduce blood lipids (plasma TG, TCH).In flax
SI is added in seed oil diet and further improves the content of EPA and DHA in chest muscle, and reduces plasma TG and TCH level,
Improve the antioxidant status of chicken.In terms of TCH content, linseed oil it is horizontal between SI there are significant reciprocation,
Middle LO+SI diet is optimal.
In short, isoflavones has the function of promoting to be converted into EPA and DHA from ALA on the basis of having ALA, from
And increase EPA and DHA content in muscle.Therefore, isoflavones and linseed oil are used cooperatively and can produce rich in n-3 not
The chicken meat product of saturated fatty acid (ALA, EPA, DHA) is made contributions to meet consumer to the needs of healthy food.
The foregoing description of the disclosed embodiments enables those skilled in the art to implement or use the present invention.
A variety of modifications of above-described embodiment will be readily apparent to those skilled in the art, it is as defined herein
General Principle can be realized in other embodiments without departing from the spirit or scope of the present invention.Therefore, of the invention
It is not intended to be limited to the embodiments shown herein, and is to fit to and the principles and novel features disclosed herein phase one
The widest scope of cause.
Claims (5)
1. application of the isoflavones in promoting chicken in EPA and DHA deposition.
2. isoflavones promotes the application in chicken in the diet or diet additive of EPA and DHA deposition in preparation.
3. a kind of method for promoting EPA and DHA deposition in chicken, which is characterized in that feed meat using the diet containing alpha-linolenic acid
Chicken, and isoflavones is added in diet.
4. a kind of method for promoting EPA and DHA deposition in chicken according to claim 1, which is characterized in that using containing Asia
The diet feeding dorking of flaxseed oil, and isoflavones is added in diet;Contain alpha-linolenic acid in the linseed oil.
5. a kind of diet for promoting EPA and DHA deposition in chicken, which is characterized in that linseed oil content is 2- in the diet
4%;Alpha-linolenic acid content is 50-60% in the linseed oil;Isoflavones additive amount is 20-60mg/ in the diet
kg。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910796957.4A CN110521874A (en) | 2019-08-27 | 2019-08-27 | A kind of method of EPA and DHA deposition in promotion chicken |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910796957.4A CN110521874A (en) | 2019-08-27 | 2019-08-27 | A kind of method of EPA and DHA deposition in promotion chicken |
Publications (1)
Publication Number | Publication Date |
---|---|
CN110521874A true CN110521874A (en) | 2019-12-03 |
Family
ID=68664629
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910796957.4A Pending CN110521874A (en) | 2019-08-27 | 2019-08-27 | A kind of method of EPA and DHA deposition in promotion chicken |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110521874A (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107087728A (en) * | 2016-02-18 | 2017-08-25 | 魏全 | A kind of feed addictive and preparation method |
CN107981087A (en) * | 2017-11-30 | 2018-05-04 | 山东和美集团有限公司 | Improve feed of laying hen Egg Quality and preparation method thereof |
CN112088977A (en) * | 2020-09-30 | 2020-12-18 | 湖南九鼎科技(集团)有限公司 | Antibiotic-free compound feed for improving lactation performance of sows |
-
2019
- 2019-08-27 CN CN201910796957.4A patent/CN110521874A/en active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107087728A (en) * | 2016-02-18 | 2017-08-25 | 魏全 | A kind of feed addictive and preparation method |
CN107981087A (en) * | 2017-11-30 | 2018-05-04 | 山东和美集团有限公司 | Improve feed of laying hen Egg Quality and preparation method thereof |
CN112088977A (en) * | 2020-09-30 | 2020-12-18 | 湖南九鼎科技(集团)有限公司 | Antibiotic-free compound feed for improving lactation performance of sows |
Non-Patent Citations (3)
Title |
---|
BO YANG ET AL.: "Soybean isoflavones improve the health benefits、flavour quality indicators and physical properties of grass carp (Ctenopharygodon idella)", 《PLOS ONE》 * |
MEGHAN L MANOR ET AL.: "Inclusion of Dietary Defatted Microalgae Dose-Dependently Enriches ω-3 Fatty Acids in Egg Yolk and Tissues of Laying Hens", 《THE JOURNAL OF NUTRITION》 * |
路延笃: "《真核微藻逆境响应关键基因及分子调控机理研究》", 31 January 2018 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Scollan et al. | Manipulating the fatty acid composition of muscle and adipose tissue in beef cattle | |
Gunalan et al. | Nutritive value of cultu red white leg shrimp Litopenaeus vannamei | |
US6054147A (en) | Method for increasing the incorporation efficiency of omega-3 highly unsaturated fatty acid in poultry meat | |
US8323708B2 (en) | Poultry meat and eggs comprising beneficial fatty acids | |
FRITSCHE et al. | Dietary n-3 fatty acids reduce antibody-dependent cell cytotoxicity and alter eicosanoid release by chicken immune cells | |
Klir et al. | Influence of pumpkin seed cake and extruded linseed on milk production and milk fatty acid profile in Alpine goats | |
Li et al. | Dietary menhaden oil reduced resistance of channel catfish (Ictalurus punctatus) to Edwardsiella ictaluri | |
Ciurescu et al. | Camelia (Camelina sativa L. Crantz Variety) oil and seeds as n-3 fatty acids rich products in broiler diets and its effects on performance, meat fatty acid composition, immune tissue weights, and plasma metabolic profile | |
CA2755438C (en) | Poultry meat and eggs comprising beneficial fatty acids | |
Barclay et al. | Production of docosahexaenoic acid from microalgae and its benefits for use in animal feeds | |
CN112219902A (en) | Oil composition suitable for foods for infants of low-age | |
Bača et al. | Effect of adding prefermented cereal product containing gamma-linolenic acid to broiler feed on production indicators and fatty acid profile of chicken breast | |
US20090196950A1 (en) | Methods of feeding pigs and products comprising beneficial fatty acids | |
Smichi et al. | Physicochemical characterization and nutritional quality of fish by-products: in vitro oils digestibility and synthesis of flavour esters. | |
KR101422062B1 (en) | Feed additive composition for producing pork containing omega-3 fatty acid and feed comprising the same | |
CN110521874A (en) | A kind of method of EPA and DHA deposition in promotion chicken | |
Haug et al. | Chicken Meat Rich in Selenium and-3 Fatty Acids | |
Anitha et al. | Production performance of broilers fed with crude rice bran oil | |
Fatima et al. | Fatty acid composition of two candidate species of aquaculture, Fenneropenaeus merguiensis and F. penicillatus (Crustacea: Decapoda) in Pakistan | |
Du et al. | Nutritional composition analysis and quality evaluation of Procambarus clarkii fed with 4 kinds of feeds. | |
CN112674337A (en) | Application of fucoxanthin and/or fucoxanthin in preparation for improving DHA level of human body | |
Bauman | Conjugated linoleic acid (CLA) and milk fat: A Good News Story | |
Chakraborty et al. | Seasonal variation of fatty acid profile in edible tissue of deep-sea whip lobster Puerulus sewelli (Decapoda, Palinuridae) | |
Sotirov et al. | Effects of dietary marine microalgae Schizochytrium limacinum on natural humoral immunity of broiler chickens. | |
Elhag et al. | Fatty acids in the inedible parts of jade perch Scortum barcoo |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |